Kalvista Pharmaceuticals Inc (KALV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
(Values in U.S. thousands)
| 04-2025 | 04-2024 | 04-2023 | 04-2022 | 04-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -183,444 | -126,644 | -92,907 | -82,339 | -46,244 |
| Depreciation Amortization | 955 | 908 | 1,706 | 3,129 | 1,222 |
| Accounts payable and accrued liabilities | -4,971 | 4,320 | 1,107 | 1,687 | 150 |
| Other Working Capital | 15,035 | 15,167 | 7,413 | -12,322 | 8,346 |
| Other Operating Activity | 19,518 | 17,018 | 7,420 | 11,711 | 6,355 |
| Operating Cash Flow | $-152,907 | $-89,231 | $-75,261 | $-78,134 | $-30,171 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -929 | -443 | -1,196 | -931 | -82 |
| Purchase Of Investment | -30,571 | -189,231 | -98,246 | -136,920 | -201,210 |
| Sale Of Investment | 122,524 | 104,955 | 140,857 | 195,711 | 53,638 |
| Investing Cash Flow | $91,024 | $-84,719 | $41,415 | $57,860 | $-147,654 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 61,687 | 150,714 | 58,116 | 1,581 | 212,117 |
| Other Financing Activity | 98,040 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $159,727 | $150,714 | $58,116 | $1,581 | $212,117 |
| Exchange Rate Effect | 2,639 | -1,213 | 1,236 | -1,167 | 511 |
| Beginning Cash Position | 31,789 | 56,238 | 30,732 | 50,592 | 15,789 |
| End Cash Position | 132,272 | 31,789 | 56,238 | 30,732 | 50,592 |
| Net Cash Flow | $100,483 | $-24,449 | $25,506 | $-19,860 | $34,803 |
| Free Cash Flow | |||||
| Operating Cash Flow | -152,907 | -89,231 | -75,261 | -78,134 | -30,171 |
| Capital Expenditure | -929 | -443 | -1,196 | -931 | -82 |
| Free Cash Flow | -153,836 | -89,674 | -76,457 | -79,065 | -30,253 |